Picture of Altamira Therapeutics logo

CYTOF — Altamira Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Brief: Auris Medical Announces Initiation Of Clinical Investigation Of Am-301 In Allergic Rhinitis

Jan 29 (Reuters) - Auris Medical Holding Ltd  EARS.O :
    * AURIS MEDICAL ANNOUNCES INITIATION OF CLINICAL
INVESTIGATION OF
AM-301 IN ALLERGIC RHINITIS
    * AURIS MEDICAL HOLDING LTD - AFFILIATE ALTAMIRA MEDICA AG
INITIATION OF A CLINICAL INVESTIGATION OF AM-301 IN ALLERGIC
RHINITIS
    * AURIS MEDICAL HOLDING LTD - MAINTAINS ITS OBJECTIVE OF
INTRODUCING AM-301 IN SELECTED MARKETS IN LATE Q2 2021
    * AURIS MEDICAL HOLDING LTD - RESULTS FROM ALLERGEN
CHALLENGE
CHAMBER STUDY ARE EXPECTED IN Q2 2021

Source text for Eikon:  ID:nGNX99TpRP 
Further company coverage:  EARS.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Altamira Therapeutics

See all news